Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02474173
Title Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

triple-receptor negative breast cancer

Therapies

Paclitaxel

Onalespib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field